<p>(<b>A</b>). Survival curves for mice pretreated with a single dose of each blinded gel or no gel (untreated) and challenged with an LD90 of HSV-29G) diluted in PBS. Survival curves for mice pretreated with a single dose of DE-021 (HEC), DE-018 (CS) or DE-020 (PRO 2000) and challenged with an LD90 of HSV-2(4674) diluted in PBS (<b>B</b>) or pooled human seminal plasma (<b>C</b>). Data were obtained from 2 independent experiments (10 mice per group). The asterisk denotes significant protection relative to HEC-treated mice (p<0.001 for virus introduced in PBS and p = 0.015 for virus introduced in seminal plasma).</p
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwi...
<p>Mice were treated daily for seven days with microbicides and twelve hours after the final applica...
<p>To remove any residual drug within the vaginal lumen prior to HSV-2 challenge in the safety studi...
<p>Mice were challenged with ∼10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</sup> pfu/mouse of HSV-2(46...
Despite significant protection in preclinical studies, cellulose sulfate (CS) failed to protect wome...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...
<p>(A) Mice were super-infected with 10<sup>6</sup> UV-irradiated Cm (UVCm) then with 5 x 10<sup>3</...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This noti...
AbstractSome subunit vaccines composed of herpes simplex virus (HSV) glycoproteins have been shown t...
<p>Animals described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.004671...
<p>CLEC4C-DTR Tg mice were injected subcutaneously with Depo-Provera or medroxyprogesterone acetate ...
BACKGROUND: Microbicides must protect against STD pathogens without causing unacceptable toxic effec...
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwi...
<p>Mice were treated daily for seven days with microbicides and twelve hours after the final applica...
<p>To remove any residual drug within the vaginal lumen prior to HSV-2 challenge in the safety studi...
<p>Mice were challenged with ∼10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</sup> pfu/mouse of HSV-2(46...
Despite significant protection in preclinical studies, cellulose sulfate (CS) failed to protect wome...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...
<p>(A) Mice were super-infected with 10<sup>6</sup> UV-irradiated Cm (UVCm) then with 5 x 10<sup>3</...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This noti...
AbstractSome subunit vaccines composed of herpes simplex virus (HSV) glycoproteins have been shown t...
<p>Animals described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.004671...
<p>CLEC4C-DTR Tg mice were injected subcutaneously with Depo-Provera or medroxyprogesterone acetate ...
BACKGROUND: Microbicides must protect against STD pathogens without causing unacceptable toxic effec...
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwi...
<p>Mice were treated daily for seven days with microbicides and twelve hours after the final applica...